Related Experiment Videos
Cyclophosphamide effects on fetal mouse cephalic acetylcholinesterase
P I Pillans1, B A Stephenson, P I Folb
1Department of Pharmacology, University of Cape Town Medical School, South Africa.
Archives of Toxicology
|January 1, 1988
Summary
Cyclophosphamide exposure in pregnant mice reduced fetal weight and brain acetylcholinesterase (AChE) activity. Early cephalic AChE elevation in embryos was linked to blood presence, not drug toxicity.
Area of Science:
- Developmental toxicology
- Neuroscience
- Biochemistry
Background:
- Cyclophosphamide (CP) is a known teratogen.
- Understanding CP's effects on embryonic and fetal development is crucial.
Purpose of the Study:
- To investigate the impact of cyclophosphamide on fetal development and acetylcholinesterase (AChE) activity.
- To determine the timing and nature of CP-induced developmental abnormalities.
Main Methods:
- Pregnant mice were administered a teratogenic dose of cyclophosphamide (CP) on day 10 of gestation.
- Embryos/fetuses were analyzed 2-9 days post-exposure for gross abnormalities, weight, cephalic AChE activity, and hemoglobin content.
Main Results:
- CP exposure led to reduced fetal and brain weights.
- Early (day 12) elevated cephalic AChE activity correlated with hemoglobin presence, likely due to blood resorption.
- Later (day 19) reduced brain AChE activity was observed, attributed to CP's growth-inhibitory effects.
Conclusions:
- CP causes significant growth inhibition and neurodevelopmental effects in mouse embryos/fetuses.
- The transient increase in cephalic AChE is an artifact of bleeding, not direct drug toxicity.
- Reduced brain AChE activity later in gestation reflects the drug's impact on brain development.